lincomycin has been researched along with Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Dai, C; He, MY; Hu, YX; Li, H; Li, RM; Li, Z; Long, D; Si, ZP; Su, W; Wang, G; Wang, J; Xie, YH; Yang, X; Zhao, R | 1 |
| Dyck, WP; Howard, PH; Viteri, AL | 1 |
2 other study(ies) available for lincomycin and Pulmonary Fibrosis
| Article | Year |
|---|---|
Gut-Lung Dysbiosis Accompanied by Diabetes Mellitus Leads to Pulmonary Fibrotic Change through the NF-κB Signaling Pathway.
Topics: Animals; Anti-Infective Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Flavonoids; Gastrointestinal Microbiome; Intestines; Lincomycin; Lung; Mice; Mice, Inbred C57BL; Microbiota; NF-kappa B; Pulmonary Fibrosis; Signal Transduction; Streptozocin | 2021 |
The spectrum of lincomycin-clindamycin colitis.
Topics: Administration, Oral; Adult; Aged; Clindamycin; Colitis; Diarrhea; Female; Humans; Injections, Intramuscular; Lincomycin; Male; Middle Aged; Proctoscopy; Pulmonary Fibrosis; Radiography; Respiratory Tract Infections; Surgical Wound Infection; Time Factors | 1974 |